Vanguard Fiduciary Trust
NXTC icon

Vanguard Fiduciary Trust’s NextCure NXTC Stock Holding History

Vanguard Fiduciary Trust’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.8K Buy
16,134
+119
+0.7% +$880 ﹤0.01% 3961
2026
Q1 		$168K Buy
+16,015
New +$196K ﹤0.01% 3565

Other funds holding NXTC

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
VA
Verdad Advisers Boston, Massachusetts $104M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Vanguard Fiduciary Trust's NXTC Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its NextCure (NXTC) stake by 0.74% in Q2 2026, buying an estimated $880 and bringing the position to 16,134 shares worth $25.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3961.

Vanguard Fiduciary Trust first reported a position in NXTC in Q1 2026 and has held it in 2 quarters since. The position peaked at $168K in Q1 2026. 30 funds tracked by Wall St. Rank hold NXTC as of Q2 2026.

  • Vanguard Fiduciary Trust held 16,134 shares of NextCure worth $25.8K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 119 NextCure shares in Q2 2026, an estimated $880.
  • NextCure made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3961 holding.
  • Vanguard Fiduciary Trust first reported a position in NextCure in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's NextCure position peaked at $168K in Q1 2026.
  • 30 funds tracked by Wall St. Rank held NextCure as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.